Expression profile analysis of colon cancer cells in response to sulindac or aspirin

Biochemical and Biophysical Research Communications

Volumn 292, Issue 2, 2002, Pages 498-512

  Iizaka, Masayoshi ^a,b   Furukawa, Yoichi ^a   Akashi, Hirofumi ^a   Nakamura, Yusuke ^a   Ogawa, Michio ^b   Tsunoda, Tatsuhiko ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Antitumor effect; Aspirin; cDNA microarray; Colon cancer; NSAID; Sulindac

Indexed keywords

ACETYLSALICYLIC ACID; COMPLEMENTARY DNA; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TIME; UNINDEXED SEQUENCE;

EID: 0036296307     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6648     Document Type: Article

References (43)

1. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
2. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac
3. Inhibition of lung tumorigenesis by NSAIDS: A working hypothesis
4. Aspirin and reduced risk of esophageal carcinoma
5. Chemopreventive effects of NSAIDs against colorectal cancer: Regulation of apoptosis and mitosis by COX-1 and COX-2
6. Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells
7. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells
8. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium
9. Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells
10. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
11. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
12. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
13. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
14. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
15. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
16. Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells
17. Identification by cDNA microarray of genes involved in ovarian carcinogenesis
18. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia
19. Genome-wide analysis of gene expression in human hep-atocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression
20. The transcriptional program in the response of human fibro-blasts to serum
21. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
22. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily
23. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities
24. Transforming growth factor-beta1-induced Smad signaling, cell-cycle arrest and apoptosis in hepatoma cells
25. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
26. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma
27. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
28. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7
29. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin
30. The role of the ataxia telangiectasia gene in the p53. WAF1/CIP1(p21)- and GADD45-mediated response to DNA damage produced by ionising radiation
31. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1
32. Comparative study of the expression of DNA mismatch repair genes, the adenomatous polyposis coli gene and growth arrest DNA damage genes in melanoma recurrences and metastases
33. An informatics approach identifying markers of chemosensitivity in human cancer cell lines
34. Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein-coupled receptors (GPRC5B and GPRC5C)
35. G protein-coupled receptor-induced sensitization of phospholipase C stimulation by receptor tyrosine kinases
36. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP
37. RAIDD is a new ’death’ adaptor molecule
38. Aspirin-induced activation of the NF-κB signaling pathway: A novel mechanism for aspirin-mediated apoptosis in colon cancer cells
39. Sulindac inhibits activation of the NF-kappaB pathway
40. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3
41. SUMO/sentrin: Protein modifiers regulating important cellular functions
42. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation
43. Profile of gene expression regulated by induced p53: Connection to the TGF-beta family